These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 19367559)

  • 1. Human cytomegalovirus targets different subsets of antigen-presenting cells with pathological consequences for host immunity: implications for immunosuppression, chronic inflammation and autoimmunity.
    Varani S; Frascaroli G; Landini MP; Söderberg-Nauclér C
    Rev Med Virol; 2009 May; 19(3):131-45. PubMed ID: 19367559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.
    Rölle A; Olweus J
    APMIS; 2009 May; 117(5-6):413-26. PubMed ID: 19400865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCMV microinfections in inflammatory diseases and cancer.
    Söderberg-Nauclér C
    J Clin Virol; 2008 Mar; 41(3):218-23. PubMed ID: 18164235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?
    Söderberg-Nauclér C
    J Intern Med; 2006 Mar; 259(3):219-46. PubMed ID: 16476101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive immunotherapy of HCMV infection.
    Kapp M; Tan SM; Einsele H; Grigoleit G
    Cytotherapy; 2007; 9(8):699-711. PubMed ID: 17917875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infection after orthotopic liver transplantation is restricted by a pre-existing antiviral immune response of the recipient.
    Bissinger AL; Oettle H; Jahn G; Neuhaus P; Sinzger C
    J Med Virol; 2004 May; 73(1):45-53. PubMed ID: 15042647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infection in immunocompetent and immunocompromised individuals--a review.
    Vancíková Z; Dvorák P
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):179-87. PubMed ID: 12476798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unravelling the interaction of human cytomegalovirus with dendritic cells by using SuperSAGE.
    Raftery MJ; Möncke-Buchner E; Matsumura H; Giese T; Winkelmann A; Reuter M; Terauchi R; Schönrich G; Krüger DH
    J Gen Virol; 2009 Sep; 90(Pt 9):2221-33. PubMed ID: 19439557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of immunity against human cytomegalovirus.
    Bennekov T; Spector D; Langhoff E
    Mt Sinai J Med; 2004 Mar; 71(2):86-93. PubMed ID: 15029400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhesus cytomegalovirus a nonhuman primate model for the study of human cytomegalovirus.
    Yue Y; Barry PA
    Adv Virus Res; 2008; 72():207-26. PubMed ID: 19081492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Cytomegalovirus and Autoimmune Diseases: Where Are We?
    Gugliesi F; Pasquero S; Griffante G; Scutera S; Albano C; Pacheco SFC; Riva G; Dell'Oste V; Biolatti M
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33567734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology.
    Gredmark-Russ S; Söderberg-Nauclér C
    Virulence; 2012 Nov; 3(7):621-34. PubMed ID: 23076329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of human cytomegalovirus infection and cellular targets.
    Gerna G; Baldanti F; Revello MG
    Hum Immunol; 2004 May; 65(5):381-6. PubMed ID: 15172435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of human cytomegalovirus (HCMV) gB genotypes in Thai patients.
    Bhattarakosol P; Chantaraarphonkun S
    Southeast Asian J Trop Med Public Health; 2007 Sep; 38(5):835-40. PubMed ID: 18041299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease.
    Bissinger AL; Sinzger C; Kaiserling E; Jahn G
    J Med Virol; 2002 Jun; 67(2):200-6. PubMed ID: 11992580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: CMV escapes!
    Froberg MK
    Ann Clin Lab Sci; 2004; 34(2):123-30. PubMed ID: 15228222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host.
    Lilleri D; Zelini P; Fornara C; Comolli G; Revello MG; Gerna G
    Clin Immunol; 2009 Jun; 131(3):395-403. PubMed ID: 19268633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine strategies against human cytomegalovirus infection.
    Zhong J; Khanna R
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):449-59. PubMed ID: 17547509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of HLA expression in human cytomegalovirus immune evasion.
    Lin A; Xu H; Yan W
    Cell Mol Immunol; 2007 Apr; 4(2):91-8. PubMed ID: 17484802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytomegalovirus glycoprotein B genotypes in immunocompetent, immunocompromised, and congenitally infected Italian populations.
    Arista S; De Grazia S; Giammanco GM; Di Carlo P; Iannitto E
    Arch Virol; 2003 Mar; 148(3):547-54. PubMed ID: 12607105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.